Total Liabilities Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual total liabilities in 2023 was 500.07 Million TWD , down -28.23% from previous year.
Apex Biotechnology Corp.'s latest quarterly total liabilities in 2024 Q2 was 549.41 Million TWD , down -10.9% from previous quarter.
Apex Biotechnology Corp. reported annual total liabilities of 696.8 Million TWD in 2022, down -24.0% from previous year.
Apex Biotechnology Corp. reported annual total liabilities of 916.91 Million TWD in 2021, down -8.79% from previous year.
Apex Biotechnology Corp. reported quarterly total liabilities of 549.41 Million TWD for 2024 Q2, down -10.9% from previous quarter.
Apex Biotechnology Corp. reported quarterly total liabilities of 477.14 Million TWD for 2023 Q3, down -26.76% from previous quarter.

Annual Total Liabilities Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Total Liabilities of Apex Biotechnology Corp. (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	500.07 Million TWD	-28.23%
2022	696.8 Million TWD	-24.0%
2021	916.91 Million TWD	-8.79%
2020	1 Billion TWD	-11.61%
2019	1.13 Billion TWD	26.14%
2018	901.69 Million TWD	-12.87%
2017	1.03 Billion TWD	34.67%
2016	768.48 Million TWD	0.5%
2015	764.69 Million TWD	-1.78%
2014	778.52 Million TWD	-3.11%
2013	803.47 Million TWD	9.29%
2012	735.18 Million TWD	89.11%
2011	388.76 Million TWD	21.26%
2010	320.59 Million TWD	5.7%
2009	303.3 Million TWD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	616.62 Million TWD	23.31%
2024 Q2	549.41 Million TWD	-10.9%
2023 Q3	477.14 Million TWD	-26.76%
2023 Q1	707.39 Million TWD	1.52%
2023 Q4	500.07 Million TWD	4.81%
2023 Q2	651.43 Million TWD	-7.91%
2023 FY	500.07 Million TWD	-28.23%
2022 Q2	899.16 Million TWD	21.95%
2022 FY	696.8 Million TWD	-24.0%
2022 Q4	696.8 Million TWD	-12.71%
2022 Q3	798.23 Million TWD	-11.22%
2022 Q1	737.29 Million TWD	-19.59%
2021 FY	916.91 Million TWD	-8.79%
2021 Q2	916.54 Million TWD	-12.22%
2021 Q3	779.42 Million TWD	-14.96%
2021 Q4	916.91 Million TWD	17.64%
2021 Q1	1.04 Billion TWD	3.87%
2020 Q2	1.17 Billion TWD	5.26%
2020 Q4	1 Billion TWD	-1.54%
2020 FY	1 Billion TWD	-11.61%
2020 Q1	1.12 Billion TWD	-1.51%
2020 Q3	1.02 Billion TWD	-13.41%
2019 Q3	1.04 Billion TWD	-11.43%
2019 FY	1.13 Billion TWD	26.14%
2019 Q1	1.01 Billion TWD	12.89%
2019 Q2	1.18 Billion TWD	16.24%
2019 Q4	1.13 Billion TWD	8.53%
2018 Q4	901.69 Million TWD	-5.79%
2018 FY	901.69 Million TWD	-12.87%
2018 Q3	957.16 Million TWD	-31.24%
2018 Q2	1.39 Billion TWD	36.28%
2018 Q1	1.02 Billion TWD	-1.3%
2017 Q2	1.17 Billion TWD	40.24%
2017 FY	1.03 Billion TWD	34.67%
2017 Q4	1.03 Billion TWD	-4.19%
2017 Q1	837.08 Million TWD	8.93%
2017 Q3	1.08 Billion TWD	-7.99%
2016 Q2	993.1 Million TWD	26.03%
2016 Q1	788 Million TWD	3.05%
2016 FY	768.48 Million TWD	0.5%
2016 Q4	768.48 Million TWD	-23.01%
2016 Q3	998.21 Million TWD	0.51%
2015 Q3	705.34 Million TWD	-31.01%
2015 Q2	1.02 Billion TWD	27.03%
2015 FY	764.69 Million TWD	-1.78%
2015 Q1	804.81 Million TWD	3.38%
2015 Q4	764.69 Million TWD	8.41%
2014 FY	778.52 Million TWD	-3.11%
2014 Q4	778.52 Million TWD	-13.61%
2014 Q3	901.14 Million TWD	-27.94%
2014 Q2	1.25 Billion TWD	62.71%
2014 Q1	768.56 Million TWD	-4.34%
2013 Q2	837.71 Million TWD	8.28%
2013 Q1	773.68 Million TWD	5.24%
2013 FY	803.47 Million TWD	9.29%
2013 Q4	803.47 Million TWD	-0.09%
2013 Q3	804.17 Million TWD	-4.0%
2012 Q2	450.9 Million TWD	12.15%
2012 FY	735.18 Million TWD	89.11%
2012 Q4	735.18 Million TWD	0.25%
2012 Q3	733.37 Million TWD	62.65%
2012 Q1	402.05 Million TWD	3.42%
2011 Q2	794.11 Million TWD	148.96%
2011 Q3	418.33 Million TWD	-47.32%
2011 FY	388.76 Million TWD	21.26%
2011 Q4	388.76 Million TWD	-7.07%
2011 Q1	318.97 Million TWD	-0.51%
2010 Q4	320.59 Million TWD	0.0%
2010 FY	320.59 Million TWD	5.7%
2009 FY	303.3 Million TWD	0.0%

Peer Total Liabilities Comparison of Apex Biotechnology Corp.

Name	Total Liabilities	Total Liabilities Difference
Sinphar Pharmaceutical Co.,Ltd.	2.85 Billion TWD	82.473%
Panion & Bf Biotech Inc.	1.32 Billion TWD	62.233%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.82 Billion TWD	72.545%
GenMont Biotech Incorporation	204.05 Million TWD	-145.061%
Abnova (Taiwan) Corporation	69.42 Million TWD	-620.313%
Adimmune Corporation	3.7 Billion TWD	86.51%
Tanvex BioPharma, Inc.	1.94 Billion TWD	74.254%
Polaris Group	1.46 Billion TWD	65.86%
Energenesis Biomedical CO.,LTD.	24.58 Million TWD	-1933.88%
UnicoCell Biomed Co., Ltd.	89.48 Million TWD	-458.819%
PELL Bio-Med Technology Co. Ltd.	236.76 Million TWD	-111.209%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

Total Liabilities Summary of Apex Biotechnology Corp.

Annual Total Liabilities Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual Total Liabilities of Apex Biotechnology Corp. (2023 - 2009)

Peer Total Liabilities Comparison of Apex Biotechnology Corp.